<DOC>
	<DOCNO>NCT01505712</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor find good way treat cancer . PURPOSE : This research study study biomarkers tissue sample patient Hodgkin lymphoma enrol ECOG-2496 clinical trial .</brief_summary>
	<brief_title>Biomarkers Tissue Samples From Patients With Hodgkin Lymphoma Enrolled ECOG-2496 Clinical Trial</brief_title>
	<detailed_description>OBJECTIVES : - To explore predictive power gene expression-based multi-gene predictor classical Hodgkin lymphoma ( cHL ) potential change clinical practice base treatment decision biological marker . OUTLINE : Archived tissue sample analyze gene expression profile use NanoString technology . Results compare patient ' treatment outcome , include failure-free survival overall survival . PROJECTED ACCRUAL : A total 306 patient ECOG-2496 ( train cohort ) 87 patient treat ABVD trial ( validation cohort ) accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Training cohort : Patients diagnose locally extensive advanced stage classical Hodgkin lymphoma ( cHL ) treat doxorubicin , bleomycin , vinblastine , dacarbazine ( ABVD ) mechlorethamine , doxorubicin hydrochloride , vinblastine , vincristine , bleomycin , etoposide , prednisone ( Stanford V ) Pretreatment formalinfixed , paraffinembedded tissue ( FFPET ) patient enrol randomized phase III ECOG2496 clinical trial Validation cohort : Patients advancedstage cHL treat ABVD British Columbia Cancer Agency ( BCCA ) Pretreatment FFPET available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
</DOC>